Basics Absci Corporation Common Stock IPO Date: July 22, 2021 Sector: Healthcare Industry: Biotech Market Cap: $689.3M Activated in VL: True Average Daily Range Avg Daily Range: $0.22 | 4.42% Avg Daily Range (30 D): $0.18 | 5.34% Avg Daily Range (90 D): $0.12 | 3.76% Institutional Daily Volume Avg Daily Volume: 1.5M Avg Daily Volume (30 D): 6.2M Avg Daily Volume (90 D): 5.25M Trade Size Avg Trade Size (Sh.): 171 Avg Trade Size (Sh.) (30 D): 240 Avg Trade Size (Sh.) (90 D): 255 Institutional Trades Total Inst.Trades: 223 Avg Inst. Trade: $1.79M Avg Inst. Trade (30 D): $1.12M Avg Inst. Trade (90 D): $1.36M Avg Inst. Trade Volume: .39M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.95M Avg Closing Trade (30 D): $1.25M Avg Closing Trade (90 D): $1.22M Avg Closing Volume: 438.64K     News Oct 14, 2025 @ 3:41 PM Absci Stock Offers High-Risk AI Biotech Exposure W... Source: Nathan Reiff Oct 9, 2025 @ 3:00 PM Computer-Aided Drug Design (CADD) Market Competiti... Source: Towards Healthcare Sep 11, 2025 @ 4:10 PM Absci Boosts AI-Powered Drug Discovery With Oracle... Source: Vandana Singh Aug 20, 2025 @ 12:00 PM Absci to Participate in Upcoming Investor Conferen... Source: Absci Corporation Jul 30, 2025 @ 5:00 PM Global Antibody Discovery Market to Observe Stupen... Source: Delveinsight Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.24 $-.21 $-.26 Diluted EPS $-.24 $-.21 $-.26 Revenue $ .59M $ 1.18M $ .67M Gross Profit $ $ $ Net Income / Loss $ -30.57M $ -26.35M $ -28.98M Operating Income / Loss $ -31.39M $ -27.73M $ -29.77M Cost of Revenue $ $ $ Net Cash Flow $ -8.84M $ 5.91M $ 3.07M PE Ratio